Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.43 |
| ▸ | GBA1 | P04062 | 7/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4360912 | 1.00 | PRKCA (0.44) | PRKCASPHK2SPHK1GBA1GAA | |
| SCHEMBL7753883 | 1.00 | PRKCA (0.44) | PRKCASPHK2SPHK1GBA1GAA | |
| SCHEMBL7344383 | 1.00 | PRKCA (0.44) | PRKCASPHK2SPHK1GBA1GAA | |
| SCHEMBL7351075 | 1.00 | PRKCA (0.44) | PRKCASPHK2SPHK1GBA1GAA | |
| SCHEMBL7344379 | 1.00 | PRKCA (0.44) | PRKCASPHK2SPHK1GBA1GAA | |
| SCHEMBL8990176 | 1.00 | PRKCA (0.44) | PRKCASPHK2SPHK1GBA1GAA | |
| SCHEMBL4980804 | 1.00 | PRKCA (0.44) | PRKCASPHK2SPHK1GBA1GAA | |
| SCHEMBL7343605 | 1.00 | PRKCA (0.44) | PRKCASPHK2SPHK1GBA1GAA | |
| SCHEMBL8915089 | 1.00 | PRKCA (0.44) | PRKCASPHK2SPHK1GBA1GAA | |
| SCHEMBL8911727 | 1.00 | PRKCA (0.44) | PRKCASPHK2SPHK1GBA1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6153589-A | FOR TREATING VIRAL INFECTIONS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-11-28 | — | — | US | disclosed |
| US-5190969-A | Epoxy derivatives of amino acids as viricides for treatment of HIV infections | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 1993-03-02 | — | — | US | disclosed |